Published in Acta Oncol on January 01, 2004
Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma. BMC Syst Biol (2010) 2.49
ErbB4 modulates tubular cell polarity and lumen diameter during kidney development. J Am Soc Nephrol (2011) 1.61
Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth. Mol Biol Cell (2005) 1.53
Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma. Br J Cancer (2005) 1.12
Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma. BMC Res Notes (2012) 0.88
Tyrosine kinase expression profile in clear cell renal cell carcinoma. World J Urol (2011) 0.86
Genetic alterations of HER genes in chromophobe renal cell carcinoma. Oncol Lett (2016) 0.78
Replication study for the association of 3 SNP loci identified in a genome-wide association study for diabetic nephropathy in European type 1 diabetes with diabetic nephropathy in Japanese patients with type 2 diabetes. Clin Exp Nephrol (2013) 0.75
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med (2014) 9.09
Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet (2009) 7.62
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol (2012) 5.71
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns. Genes Cancer (2010) 3.78
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96
Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med (2005) 2.56
Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer. Mol Cancer Ther (2004) 2.47
Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data. Eur Urol (2011) 2.45
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer. J Clin Oncol (2012) 2.45
Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res (2008) 2.24
LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J (2004) 2.20
Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res (2005) 2.11
Urinary bladder cancer treated with radical cystectomy: perioperative parameters and early complications prospectively registered in a national population-based database. Scand J Urol (2014) 2.07
N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort. Cancer Epidemiol Biomarkers Prev (2013) 2.01
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells. Cancer Res (2005) 1.93
Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells. Clin Cancer Res (2006) 1.85
High frequency of BRAF V600E mutations in ameloblastoma. J Pathol (2014) 1.79
Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. J Clin Invest (2008) 1.76
Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet (2010) 1.74
Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray. Eur Urol (2006) 1.66
Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res (2005) 1.66
Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2012) 1.61
ErbB4 modulates tubular cell polarity and lumen diameter during kidney development. J Am Soc Nephrol (2011) 1.61
Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol (2012) 1.60
Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability. Eur Urol (2009) 1.58
ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. Clin Cancer Res (2002) 1.58
Role of ErbB4 in breast cancer. J Mammary Gland Biol Neoplasia (2008) 1.57
High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer (2009) 1.55
Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth. Mol Biol Cell (2005) 1.53
Verotoxin-1 induction of apoptosis in Gb3-expressing human glioma cell lines. Cancer Biol Ther (2006) 1.46
Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Acta Neuropathol (2004) 1.46
Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol (2012) 1.46
Defecation disturbances after cystectomy for urinary bladder cancer. BJU Int (2010) 1.46
Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis (2008) 1.45
Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma. Eur Urol (2013) 1.45
LRIG inhibitors of growth factor signalling - double-edged swords in human cancer? Eur J Cancer (2007) 1.44
Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival. Clin Cancer Res (2009) 1.42
Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms. Proc Natl Acad Sci U S A (2008) 1.39
Angiopoietin-regulated recruitment of vascular smooth muscle cells by endothelial-derived heparin binding EGF-like growth factor. FASEB J (2003) 1.38
Association of Wwox with ErbB4 in breast cancer. Cancer Res (2007) 1.37
A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Hum Mol Genet (2011) 1.34
Is LRIG1 a tumour suppressor gene at chromosome 3p14.3? Acta Oncol (2002) 1.34
Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet (2013) 1.34
Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J Neurooncol (2003) 1.31
Comprehensive analysis of DNA repair gene variants and risk of meningioma. J Natl Cancer Inst (2008) 1.30
ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivo. Mol Cell Biol (2009) 1.28
Function of ERBB4 is determined by alternative splicing. Cell Cycle (2011) 1.26
Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer (2006) 1.25
Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention. World J Urol (2010) 1.24
The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells. Mol Biol Cell (2006) 1.23
Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients. Clin Cancer Res (2003) 1.23
Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer (2003) 1.21
Inhibition by the soluble syndecan-1 ectodomains delays wound repair in mice overexpressing syndecan-1. J Biol Chem (2004) 1.20
Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet (2007) 1.19
LRIG1 protein in human cells and tissues. Cell Tissue Res (2003) 1.18
Telomere length in peripheral blood predicts survival in clear cell renal cell carcinoma. Cancer Res (2009) 1.18
The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea. Genomics (2004) 1.17
Dysregulated secretoglobin expression in human lung cancers. Lung Cancer (2003) 1.17
A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta Oncol (2010) 1.17
Fruits and vegetables and renal cell carcinoma: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer (2006) 1.15
The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma. Clin Cancer Res (2005) 1.15
Common variation at 10p12.31 near MLLT10 influences meningioma risk. Nat Genet (2011) 1.12
Somatic mutations of ErbB4: selective loss-of-function phenotype affecting signal transduction pathways in cancer. J Biol Chem (2008) 1.11
The notch and TGF-β signaling pathways contribute to the aggressiveness of clear cell renal cell carcinoma. PLoS One (2011) 1.11
Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors. Acta Neuropathol (2006) 1.10
Endothelial cell-matrix interactions. Microsc Res Tech (2003) 1.09
Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort. Am J Epidemiol (2014) 1.09
An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol Biomarkers Prev (2007) 1.09
Pim-1 kinase expression predicts radiation response in squamocellular carcinoma of head and neck and is under the control of epidermal growth factor receptor. Neoplasia (2009) 1.09
LRIG1 expression in colorectal cancer. Acta Oncol (2007) 1.08
Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer. PLoS One (2009) 1.08
Cell death or survival promoted by alternative isoforms of ErbB4. Mol Biol Cell (2010) 1.07
Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden. J Neurooncol (2003) 1.05
Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer Res (2011) 1.05
Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival. Neuropathology (2009) 1.05
Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys (2005) 1.04
Characterization and tissue-specific expression of human LRIG2. Gene (2004) 1.04
The common D302H variant of CASP8 is associated with risk of glioma. Cancer Epidemiol Biomarkers Prev (2008) 1.02
LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer. Int J Cancer (2011) 1.01
ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases. Anticancer Res (2009) 1.01
Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. Eur J Cancer (2009) 1.00
Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma. Neuroepidemiology (2002) 0.99
LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix. Acta Oncol (2010) 0.99
Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas. Genes Chromosomes Cancer (2002) 0.98